{
  "docId": "019de515-e1f4-739b-a349-913fc7c75e72",
  "docSlug": "3b70dadd72cd7c3c7226b36c1da9b327",
  "documentTitle": "Allurion | SPAC Presentation Deck | 25 slides",
  "authorId": "allurion",
  "authorName": "Allurion",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 25,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "other",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de515-e1f4-739b-a349-913fc7c75e72/21",
  "deckHref": "/decks/019de515-e1f4-739b-a349-913fc7c75e72",
  "deckJsonHref": "/decks/019de515-e1f4-739b-a349-913fc7c75e72.json",
  "deckAnchorHref": "/decks/019de515-e1f4-739b-a349-913fc7c75e72#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.29,
        "w": 0.847,
        "x": 0.078,
        "y": 0.159
      },
      "kind": "diagram",
      "text": "W0, W16, W24, W40, W48; Balloon 1, Break, Balloon 2, Break; Treatment Group (n=250), Moderate Intensity Lifestyle Therapy; Control Group (n=250), Moderate Intensity Lifestyle Therapy",
      "attrs": {},
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8134db5-4c7d-4a9b-a16a-250937a8ea6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.066,
        "w": 0.42,
        "x": 0.433,
        "y": 0.566
      },
      "kind": "list",
      "text": "3.0% total body weight loss (TBWL) superiority margin at 48 weeks",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06db3867-b947-4e9b-9819-1fa6979a919a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.047,
        "w": 0.18,
        "x": 0.76,
        "y": 0.75
      },
      "kind": "list",
      "text": "48-week endpoint may open door to reimbursement",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "233028ec-398a-446a-b818-a76a669d2758",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.066,
        "w": 0.32,
        "x": 0.078,
        "y": 0.566
      },
      "kind": "list",
      "text": "Co-Primary Endpoints: 50% responder rate (>5% TBWL) at 48 weeks",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f3a2f9b-df43-4717-9f59-252b7c31d647",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.28,
        "x": 0.12,
        "y": 0.739
      },
      "kind": "list",
      "text": "Open-label, sequential balloon design is expected to boost weight loss and durability",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2507345-5b06-49c5-99d4-7eeadb8cfe9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.047,
        "w": 0.18,
        "x": 0.47,
        "y": 0.75
      },
      "kind": "list",
      "text": "Conservative sample size and powering",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca556f8e-5d61-460f-bec4-895fdb16b501",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.017,
        "w": 0.279,
        "x": 0.078,
        "y": 0.079
      },
      "kind": "paragraph",
      "text": "Enrollment begun in May 2022",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15c711ec-ccbe-4ae3-a8f3-ba91dc3c2ff7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.009,
        "w": 0.16,
        "x": 0.019,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "IDE = Investigational Device Exemption",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3505755a-2eed-4131-a94a-a4724f8b1ad4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.59,
        "x": 0.078,
        "y": 0.048
      },
      "kind": "title",
      "text": "IDE for AUDACITY Trial Has Been Approved by FDA",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5077a9e6-ad77-46d0-b06e-28633765badc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}